Answer
Filgotinib maleate (Jyseleca) is indicated for adults with moderate to severe active rheumatoid arthritis who have responded inadequately to, or are intolerant to, one or more disease-modifying anti-rheumatic drugs (DMARDs), as monotherapy or with methotrexate.
Sources for this answer
- Jyseleca 100 mg film-coated tabletsAlfasigma UK Limited (formerly Galapagos Biotech Limited) · emc · SmPC §4.1 Therapeutic Indications · Version 20Document updated
Sources checked